FDA seeks comments on the burden on importers from its information collections under the Foreign Supplier Verification Program regulations, it said in a notice released Jan. 27. The agency is set to request an extension from the Office of Management and Budget for existing information collection requirements under FSVP. The approval would cover reporting and record-keeping requirements. Comments on the requirements and FDA’s estimate of their burden on importers are due March 29.

On Jan. 25, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Jan. 24, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Jan. 21, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Jan. 20, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Jan. 19, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA has issued its Enforcement Report for Jan. 19, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.

On Jan. 18, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Jan. 13, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Jan. 12, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: